Home
About
Overview
Sharing Data
ORCID
Help
History (14)
First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists : A Cost-Effectiveness Study.
Insight on Diagnosis and Treatment From Over a Decade of Research Through the University of Chicago Monogenic Diabetes Registry.
First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists.
Doxorubicin-associated takotsubo cardiomyopathy in a patient with adult T-cell leukemia/lymphoma.
Monogenic Diabetes: Next Generation Diagnosis, Treatment and Complications
See All 14 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Monogenic Diabetes: Next Generation Diagnosis, Treatment and Complications
Overview
sponsor award id
R01DK104942
Biography
contributor
Principal Investigator
Co-Investigator
Time
start date
2016-01-08
end date
2024-12-31